Combining Biomedical Innovation and Patient Care: a Fireside Chat with Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute
The pandemic required research hospitals to pivot operations dramatically to deploy urgent COVID-19 responses while increasing resilience for continuing clinical research on other diseases. More than 1,000 clinical trials are in progress at the Dana-Farber Cancer Institute. This fireside chat will explore that organization’s lessons and the perspective of Dr. Laurie Glimcher on combining biomedical innovation and patient care. Join Dr. Glimcher and our moderator, Margaret Anderson, an expert in supporting innovation on behalf of patients, for this session on the frontier of health care.